Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stifel Hires Dae Gon Ha as Director Covering Biotech Sector
Stifel Financial CorporationJanuary 13, 2021 GMT
ST. LOUIS, Jan. 13, 2021 (GLOBE NEWSWIRE) Stifel Financial Corp. (NYSE: SF) today announced that Dae Gon Ha, Ph.D., has joined the firm as a Director and Equity Research Analyst covering the biotechnology sector. He is based in the firm’s Boston office.
Dr. Ha most recently served as a Vice President in biotechnology research at BTIG. Prior to BTIG, he was Vice President in biotechnology research at SVB Leerink, where he focused on rare disease companies. Dr. Ha completed his post-doctoral research fellowship at Harvard Medical School, where he initiated, designed, and executed a chemical compound screen with the goal of identifying novel antibiotics. He received a Ph.D. in Microbiology and Immunology from Dartmouth College and a B.A. in Biology from Grinnell College.
New Eaton Partners Survey Indicates High Expectations for Private Capital Market Performance in 2021 wboc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wboc.com Daily Mail and Mail on Sunday newspapers.